These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11200711

  • 21. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA.
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [Abstract] [Full Text] [Related]

  • 22. [Auto-antibody profile and breast feeding in type 1 diabetic patients].
    Pérez-Bravo F, Riesco V, Albala C, Oyarzún A, Santos JL, Carrasco E.
    Rev Med Chil; 2001 Jun; 129(6):611-9. PubMed ID: 11510200
    [Abstract] [Full Text] [Related]

  • 23. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
    Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA.
    Neurology; 2005 Feb 22; 64(4):743-5. PubMed ID: 15728308
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J, Bárová H, Hill M, Masek Z.
    Vnitr Lek; 2002 Jun 22; 48(6):490-9. PubMed ID: 12132349
    [Abstract] [Full Text] [Related]

  • 26. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F.
    Diabetes; 2008 May 22; 57(5):1276-83. PubMed ID: 18332100
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M, Skrha J, Límanová Z, Hilgertová J.
    Sb Lek; 1999 May 22; 100(3):205-11. PubMed ID: 11221467
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.
    Pediatr Diabetes; 2005 Dec 22; 6(4):184-92. PubMed ID: 16390386
    [Abstract] [Full Text] [Related]

  • 31. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
    Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G.
    Diabet Med; 2004 May 22; 21(5):456-9. PubMed ID: 15089790
    [Abstract] [Full Text] [Related]

  • 32. Immunomodulation with human recombinant autoantigens.
    Lernmark A, Agardh CD.
    Trends Immunol; 2005 Nov 22; 26(11):608-12. PubMed ID: 16153889
    [Abstract] [Full Text] [Related]

  • 33. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H, Fernlund P, Sundkvist G.
    Clin Chem; 1997 Dec 22; 43(12):2358-63. PubMed ID: 9439455
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.
    J Autoimmun; 2005 Mar 22; 24(2):153-67. PubMed ID: 15829408
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin L, Bruining J, Maclaren N, Akerblom HK, Baekkeskov S.
    J Clin Invest; 1996 Jun 15; 97(12):2772-83. PubMed ID: 8675688
    [Abstract] [Full Text] [Related]

  • 39. Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications.
    Hermitte L, Atlan-Gepner C, Mattei C, Dufayet D, Jannot MF, Christofilis MA, Nervi S, Vialettes B.
    Diabet Med; 1998 Jul 15; 15(7):586-91. PubMed ID: 9686699
    [Abstract] [Full Text] [Related]

  • 40. Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus.
    House DV, Winter WE.
    Clin Lab Med; 1997 Sep 15; 17(3):499-545. PubMed ID: 9316771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.